Can We Afford the Future of Medicine? The Promise and Price of Cell and Gene Therapies

icon mic

September 21, 2026

The promise of cell and gene therapies is big. They have the ability to address the underlying genetic causes of disease, offering new possibilities for people with serious and previously difficult-to-treat conditions. But as cell and gene therapies move beyond just treating rare diseases to also address conditions such as high cholesterol, the market is being shaped by new questions about access and value. The evidence base for existing therapies also continues to evolve, particularly as researchers assess long-term outcomes for treatments that are often approved based on small patient datasets.

Sarah Emond, President and CEO of the Institute for Clinical and Economic Review (ICER), returns to the Business Group on Health podcast to discuss what has changed in the cell and gene therapy market. The conversation explores evolving evidence, how therapies are priced and paid for, provider capacity, regulatory developments, and the long-term durability of treatment outcomes.

As the number of people who become eligible for cell and gene therapies grows, employers face the challenge of connecting employees and their families to potentially life-changing therapies, while also assessing value and managing financial risk.

Tune in for practical insights into new developments, emerging payment options and how stakeholders across the healthcare ecosystem can work together to balance innovation, access and affordability.

SPEAKERS

Sarah Emond | President and CEO, Institute for Clinical and Economic Review (ICER)

Ellen Kelsay | President and CEO, Business Group on Health

Download Transcript 

Duration 33 min

Subscribe To The Podcast

All Podcasts

Showing items 81-90 of 132
Nov 14, 2022
Forget What You Think You Know About Gen Z
On this episode of the Business Group on Health Podcast, we discuss defining attributes of Gen Zers, examining what shaped them,...
Read more
Oct 17, 2022
Disability Inclusion is Workplace Inclusion
On this episode of the Business Group on Health Podcast, we speak with Crosby Cromwell of The Valuable 500 about why diversity,...
Read more
Sep 19, 2022
Demonstrating LGBTQ Allyship through Inclusive and...
More than ever, LGBTQ+ equality is on the minds of employers and this episode of the Business Group on Health Podcast tackles some...
Read more
Aug 22, 2022
Recovery is Possible and Other Essential Things to...
One third of U.S. adults experience alcohol use disorder in their lifetime, according to today’s Business Group on Health Podcast...
Read more
Aug 08, 2022
"We Can Make Strides in Preventing...
On today’s episode of the Business Group on Health Podcast, we speak with Dr. Christine Yu Moutier, psychiatrist and Chief Medical...
Read more
Jul 25, 2022
Is the Future of Medicine Functional Medicine? A...
On today’s episode of the Business Group on Health Podcast, we speak with Dr. Mark Hyman, multi-time #1 New York Times Bestselling...
Read more
Jul 11, 2022
When Pay Isn’t Enough: Driving Business Value...
On today’s episode of the Business Group on Health Podcast, we speak with Timothy Flacke and explore the question: “what more do...
Read more
Jun 21, 2022
Conversations about End-of-Life Care are Key to...
Dr. Shoshana Ungerleider talks about grief, death and dying and caregiving, as well how employers can create a space that fosters...
Read more
Jun 06, 2022
The Impact of Climate Change on Our Collective...
Dr. Susan Clayton discusses the relationship between warming weather and our mood and sleep, the emotional toll on people...
Read more
May 23, 2022
Virtual Reality: The Next Frontier in Health Care
Dr. Greenleaf discusses the many applications of VR, its advantages as a health and well-being tool, and what the next decade...
Read more
Showing items 81-90 of 132